Superworth

Wave Life Sciences revenue WVE

Sales by quarter and over the last twelve months, from 2015.

Last 12 months, to Sep 30, 2026
$70.9M
Latest quarter, Q3 FY26
$13.2M
+73% on a year earlier
Fiscal year 2025
$42.7M
−62% on the year before

Wave Life Sciences' revenue was $70.9M over the twelve months to Sep 30, 2026.

In its latest quarter, Q3 FY26, it was $13.2M, up 73% on the same quarter a year before.

Over the five fiscal years to FY2025 it grew 22% a year on average.

Revenue over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearRevenueChange
FY2025$42.7M−62%
FY2023$113.3M+3005%
FY2022$3.6Mn/a
FY2021n/an/a
FY2020$20.1M+26%
FY2019$16M+11%
FY2018$14.4M+270%
FY2017$3.9Mn/a
FY2016n/an/a
FY2015$152Kn/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedRevenueOn a year earlierLast 12 months
Q3 FY26$13.2M+73%$70.9M
Q2 FY26$2.3M−74%$65.4M
Q1 FY26$38.2M+317%$71.8M
Q4 FY25$17.2Mn/a$42.7M
Q3 FY25$7.6Mn/an/a
Q2 FY25$8.7M−56%n/a
Q1 FY25$9.2M−27%n/a
Q2 FY24$19.7M−11%$110.5M
Q1 FY24$12.5M−3%$112.9M
Q4 FY23$29.1M+2245%$113.3M
Q3 FY23$49.2M+17168%$85.5M
Q2 FY23$22.1M+5795%$36.6M

Against its peers

Companies in Drug Manufacturers - General nearest Wave Life Sciences' size, closest first, today.

CompanyRevenue, 12 monthsGrowth
WVEWave Life Sciences$70.9M
COLLCollegium Pharmaceutical$808.2M+14% a year
ABUSArbutus Biopharma$181.7M
ZVRAZevra Therapeutics$136.1M+119% a year
IRWDIronwood Pharmaceuticals$389.3M+26% a year
PBYIPuma Biotechnology$231.2M−3% a year
ARVNArvinas$316.7M−15% a year
CRMDCorMedix$462.2M+281% a year
AMPHAmphastar Pharmaceuticals$730M+1% a year
OMEROmerosn/m
ANABAnaptysbion/m
Peer median$353M

What the revenue tells you

Total sales in the period. On the company page, quarterly bars or the trailing twelve months (TTM), which smooths seasonality.

Growing revenue with shrinking margins is a warning, not a win.

More on Wave Life Sciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.